Mount Sinai Health System Company Research Report
Company Overview
- Name: Mount Sinai Health System
- Mission: To advance health for all people, everywhere, by taking on complex health care challenges—discovering and applying new scientific learning and knowledge; developing safer, more effective treatments; educating the next generation of medical leaders and innovators; and supporting local communities by delivering high-quality care to all who need it.
- Founding: The Mount Sinai Health System was created in July 2013 from the combination of the Mount Sinai Medical Center and Continuum Health Partners.
- Key People:
- Brendan G. Carr, MD, MA, MS, Chief Executive Officer
- David L. Reich, MD, President of The Mount Sinai Hospital and Mount Sinai Queens
- Beth Oliver, DNP, RN, FAAN, Chief Nurse Executive
- Headquarters: New York, NY, USA
- Number of Employees: Approximately 48,000
- Revenue: No information is available
- Known For: Excellence in research, patient care, and education across a range of specialties; it is a leader in diversity, equity, and inclusion, and recognized as an LGBTQ+ Healthcare Equality Leader.
Products and Services
- Health Services:
- Full-service hospitals offering a wide range of medical services.
- Multispecialty services and a network of ambulatory practices.
- Specialized centers for Cardiology, Oncology, Neuroscience, and more.
- Nursing and graduate medical education programs.
- Clinical trials and research institutes focused on diseases such as diabetes, cardiovascular diseases, cancer, and more.
Recent Developments
New Partnerships and Recognitions
- Magnet Recognition: The Mount Sinai Hospital achieved its fifth consecutive Magnet Recognition® for nursing excellence.
- U.S. News & World Report Rankings: Listed among the nation's top hospitals with several top-20 specialty rankings, such as Geriatrics, Cardiology, and Cancer.
- LGBTQ+ Healthcare Equality Leader: Achieved top score in the Human Rights Campaign Foundation’s 2024 Healthcare Equality Index.
Research and Innovations
- Innovative Antibody Platform (AMETA): Developed a platform to enhance therapeutic potential against rapidly mutating viruses like SARS-CoV-2.
- Ovarian Cancer Immunotherapy Resistance: Discovered how ovarian cancer cells manipulate their environment to resist immunotherapy and identified potential therapeutic approaches.
Community Engagement and Health Initiatives
- Hypertension Series in Harlem: Launched a community hypertension program in collaboration with Harlem Healthy Hearts and the Greater New York City Black Nurses Association.
Major Research Studies
- Acute Myeloid Leukemia Study: Identified RAS-mutant leukemia stem cells driving resistance to venetoclax treatment.
- ECLIPSE Study: Found that the use of an orbital atherectomy device does not improve cardiac stenting outcomes and should be reserved for extreme cases.
Conclusion
The Mount Sinai Health System is a leader in providing high-quality healthcare and advancing medical research. It has been consistently recognized for its excellence in multiple specialties and commitment to inclusion and diversity. The system is extensive, with numerous hospitals and medical centers aimed at providing comprehensive care using innovative approaches.
